Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$112.47 - $130.98 $26,992 - $31,435
240 Added 0.79%
30,500 $3.92 Million
Q1 2023

May 10, 2023

BUY
$104.0 - $122.92 $12,480 - $14,750
120 Added 0.4%
30,260 $3.52 Million
Q4 2022

Feb 09, 2023

BUY
$84.98 - $122.67 $6,798 - $9,813
80 Added 0.27%
30,140 $3.41 Million
Q2 2022

Aug 12, 2022

BUY
$67.99 - $132.89 $1.52 Million - $2.97 Million
22,315 Added 288.12%
30,060 $2.24 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $3,246 - $4,070
25 Added 0.32%
7,745 $4.16 Million
Q2 2021

Aug 16, 2021

SELL
$80.99 - $107.93 $3,644 - $4,856
-45 Reduced 0.58%
7,720 $3.3 Million
Q1 2021

May 17, 2021

BUY
$84.79 - $104.74 $19,077 - $23,566
225 Added 2.98%
7,765 $2.79 Million
Q4 2020

Feb 16, 2021

SELL
$78.0 - $104.5 $546 - $731
-7 Reduced 0.09%
7,540 $2.79 Million
Q3 2020

Nov 16, 2020

SELL
$95.51 - $112.95 $34,192 - $40,436
-358 Reduced 4.53%
7,547 $3.11 Million
Q2 2020

Aug 12, 2020

SELL
$62.68 - $105.34 $169,549 - $284,944
-2,705 Reduced 25.49%
7,905 $3.21 Million
Q1 2020

May 15, 2020

BUY
$47.79 - $75.63 $36,081 - $57,100
755 Added 7.66%
10,610 $2.86 Million
Q4 2019

Jan 14, 2020

SELL
$36.62 - $57.29 $1.19 Million - $1.87 Million
-32,600 Reduced 76.79%
9,855 $2.16 Million
Q3 2019

Oct 31, 2019

BUY
$35.53 - $43.8 $380,881 - $469,535
10,720 Added 33.78%
42,455 $6.34 Million
Q2 2019

Jul 31, 2019

BUY
$27.84 - $38.92 $70,017 - $97,883
2,515 Added 8.61%
31,735 $4.76 Million
Q1 2019

Apr 30, 2019

SELL
$28.07 - $38.18 $110,034 - $149,665
-3,920 Reduced 11.83%
29,220 $3.48 Million
Q4 2018

Feb 08, 2019

BUY
$26.99 - $37.37 $654,237 - $905,848
24,240 Added 272.36%
33,140 $3.97 Million
Q3 2018

Nov 13, 2018

BUY
$23.35 - $36.72 $207,815 - $326,808
8,900 New
8,900 $1.27 Million
Q4 2017

Feb 13, 2018

SELL
$11.12 - $15.38 $93,730 - $129,638
-8,429 Closed
0 $0
Q3 2017

Oct 30, 2017

BUY
$11.36 - $18.98 $95,753 - $159,982
8,429
8,429 $412,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $33.2B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Tocqueville Asset Management L.P. Portfolio

Follow Tocqueville Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.